Notably, ASS1 exerts hepatoprotective effects in the interplay between OSA and NAFLD; hence, arginine supplementation holds promise as a therapeutic intervention for liver ailments. The gene discussed is ASS1; the disease is metabolic dysfunction-associated steatotic liver disease.